Record Information |
---|
Version | 2.0 |
---|
Created at | 2006-08-13 19:32:00 UTC |
---|
Updated at | 2021-06-29 00:53:48 UTC |
---|
NP-MRD ID | NP0000034 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Anatabine |
---|
Description | Anatabine is one of the minor alkaloids found in plants in the family Solanaceae, which includes the tobacco plant and tomato. Commercial tobacco plants typically produce alkaloids at levels between 2% and 4% of total dry weight, with nicotine accounting for about 90% of the total alkaloid content, and the related compounds anabatine, nornicotine, and anabasine making up nearly all the rest. These compounds are thought to be biologically active, and part of plants' natural defense system against insects. It belongs to the class of organic compounds known as aralkylamines. These are alkylamines in which the alkyl group is substituted at one carbon atom by an aromatic hydrocarbyl group. Anatabine is tobacco alkaloid in urine of smokers and smokeless tobacco users (PMID: 8245163 ). This Nicotine-related alkaloid is an inhibitor of human cytochrome P-450 2A6 (PMID: 14757175 ). |
---|
Structure | C1N[C@@H](CC=C1)C1=CN=CC=C1 InChI=1S/C10H12N2/c1-2-7-12-10(5-1)9-4-3-6-11-8-9/h1-4,6,8,10,12H,5,7H2/t10-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(-)-Anatabine | Kegg |
|
---|
Chemical Formula | C10H12N2 |
---|
Average Mass | 160.2157 Da |
---|
Monoisotopic Mass | 160.10005 Da |
---|
IUPAC Name | (2S)-1,2,3,6-tetrahydro-2,3'-bipyridine |
---|
Traditional Name | anatabine |
---|
CAS Registry Number | 581-49-7 |
---|
SMILES | C1N[C@@H](CC=C1)C1=CN=CC=C1 |
---|
InChI Identifier | InChI=1S/C10H12N2/c1-2-7-12-10(5-1)9-4-3-6-11-8-9/h1-4,6,8,10,12H,5,7H2/t10-/m0/s1 |
---|
InChI Key | SOPPBXUYQGUQHE-JTQLQIEISA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 600 MHz, Methanol, simulated) | varshavi.d26@gmail.com | Not Available | Not Available | 2021-08-12 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, Methanol, simulated) | varshavi.d26@gmail.com | Not Available | Not Available | 2021-08-12 | View Spectrum |
| Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as aralkylamines. These are alkylamines in which the alkyl group is substituted at one carbon atom by an aromatic hydrocarbyl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic nitrogen compounds |
---|
Class | Organonitrogen compounds |
---|
Sub Class | Amines |
---|
Direct Parent | Aralkylamines |
---|
Alternative Parents | |
---|
Substituents | - Aralkylamine
- Pyridine
- Hydropyridine
- Heteroaromatic compound
- Azacycle
- Organoheterocyclic compound
- Secondary amine
- Secondary aliphatic amine
- Organopnictogen compound
- Hydrocarbon derivative
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Liquid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | 145.5 °C | Not Available | Water Solubility | 1000 mg/mL | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Jacob P 3rd, Yu L, Liang G, Shulgin AT, Benowitz NL: Gas chromatographic-mass spectrometric method for determination of anabasine, anatabine and other tobacco alkaloids in urine of smokers and smokeless tobacco users. J Chromatogr. 1993 Sep 8;619(1):49-61. [PubMed:8245163 ]
- Denton TT, Zhang X, Cashman JR: Nicotine-related alkaloids and metabolites as inhibitors of human cytochrome P-450 2A6. Biochem Pharmacol. 2004 Feb 15;67(4):751-6. [PubMed:14757175 ]
- Jacob P 3rd, Hatsukami D, Severson H, Hall S, Yu L, Benowitz NL: Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1668-73. [PubMed:12496059 ]
- Alzualde A, Jaka O, Latino DARS, Alijevic O, Iturria I, de Mendoza JH, Pospisil P, Frentzel S, Peitsch MC, Hoeng J, Koshibu K: Effects of nicotinic acetylcholine receptor-activating alkaloids on anxiety-like behavior in zebrafish. J Nat Med. 2021 Jul 15. pii: 10.1007/s11418-021-01544-8. doi: 10.1007/s11418-021-01544-8. [PubMed:34264421 ]
- Hawkey AB, Hoeng J, Peitsch MC, Levin ED, Koshibu K: Subchronic effects of plant alkaloids on anxiety-like behavior in zebrafish. Pharmacol Biochem Behav. 2021 Aug;207:173223. doi: 10.1016/j.pbb.2021.173223. Epub 2021 Jun 28. [PubMed:34197843 ]
- Patalas-Krawczyk P, Malinska D, Walczak J, Kratzer G, Prill M, Michalska B, Drabik K, Titz B, Eb-Levadoux Y, Schneider T, Szymanski J, Hoeng J, Peitsch MC, Duszynski J, Szczepanowska J, Van der Toorn M, Mathis C, Wieckowski MR: Effects of plant alkaloids on mitochondrial bioenergetic parameters. Food Chem Toxicol. 2021 Aug;154:112316. doi: 10.1016/j.fct.2021.112316. Epub 2021 Jun 3. [PubMed:34089800 ]
- Callahan PM, Terry AV Jr, Peitsch MC, Hoeng J, Koshibu K: Differential effects of alkaloids on memory in rodents. Sci Rep. 2021 May 10;11(1):9843. doi: 10.1038/s41598-021-89245-w. [PubMed:33972592 ]
- Marescotti D, Lo Sasso G, Guerrera D, Renggli K, Ruiz Castro PA, Piault R, Jaquet V, Moine F, Luettich K, Frentzel S, Peitsch MC, Hoeng J: Development of an Advanced Multicellular Intestinal Model for Assessing Immunomodulatory Properties of Anti-Inflammatory Compounds. Front Pharmacol. 2021 Apr 16;12:639716. doi: 10.3389/fphar.2021.639716. eCollection 2021. [PubMed:33935729 ]
- Morin A, Mouzon B, Ferguson S, Paris D, Saltiel N, Browning M, Mullan M, Crawford F: A 3-month-delayed treatment with anatabine improves chronic outcomes in two different models of repetitive mild traumatic brain injury in hTau mice. Sci Rep. 2021 Apr 12;11(1):7900. doi: 10.1038/s41598-021-87161-7. [PubMed:33846461 ]
|
---|